The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane
Open accessAbstract
Colistin is an antibiotic of last resort, but has poor efficacy and resistance is a growing problem. Whilst it is well established that colistin disrupts the bacterial outer membrane (OM) by selectively targeting lipopolysaccharide (LPS), it was unclear how this led to bacterial killing. We discovered that MCR-1 mediated colistin resistance in Escherichia coli is due to modified LPS at the cytoplasmic rather than OM. In doing so, we also demonstrated that colistin exerts bactericidal activity by targeting LPS in the cytoplasmic membrane (CM). We then exploited this information to devise a new therapeutic approach. Using the LPS transport inhibitor murepavadin, we were able to cause LPS accumulation in the CM of Pseudomonas aeruginosa , which resulted in increased susceptibility to colistin in vitro and improved treatment efficacy in vivo. These findings reveal new insight into the mechanism by which colistin kills bacteria, providing the foundations for novel approaches to enhance therapeutic outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Second, out membrane proteins (OMPs) contributes to nutrient exchange, adhesion, and antibiotic resistance.19”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481
Mechanism of Assembly of the Outer Membrane of Salmonella typhimurium
Osborn, M. J., Gander, J. E., Parisi, E., & Carson, J. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45127-2 · Cited by 1,568
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,447
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
European Respiratory Society guidelines for the management of adult bronchiectasis
Polverino, E., Goeminne, P. C., McDonnell, M. J., Aliberti, S., Marshall, S. E., Loebinger, M. R., Murris, M., Cantón, R., Torres, A., Dimakou, K., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00629-2017 · Cited by 1,333
The relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)
El-Sayed Ahmed, M. A. E.-G., Zhong, L.-L., Shen, C., Yang, Y., Doi, Y., & Tian, G.-B. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1754133 · Cited by 761
Paul, M., Daikos, G. L., Durante-Mangoni, E., Yahav, D., Carmeli, Y., Benattar, Y. D., Skiada, A., Andini, R., Eliakim-Raz, N., Nutman, A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30099-9 · Cited by 623
Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial
Lee, D. G., Urbach, J. M., Wu, G., Liberati, N. T., Feinbaum, R. L., Miyata, S., Diggins, L. T., He, J., Saucier, M., Déziel, E., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-10-r90 · Cited by 603
Colistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Fluorometric assessment of Gram-negative bacterial permeabilization
Helander, I. M., & Mattila-Sandholm, T. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.00971.x · Cited by 537
Pushing the envelope: LPS modifications and their consequences
Simpson, B. W., & Trent, M. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0201-x · Cited by 509
Carroll, L. M., Gaballa, A., Guldimann, C., Sullivan, G., Henderson, L. O., & Wiedmann, M. (2019) · mBio · doi:10.1128/mbio.00853-19 · Cited by 506
Identification of novel mobile colistin resistance gene mcr-10
Wang, C., Feng, Y., Liu, L., Wei, L., Kang, M., & Zong, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1732231 · Cited by 456
Polymyxin: Alternative Mechanisms of Action and Resistance
Trimble, M. J., Mlynárčik, P., Kolář, M., & Hancock, R. E. W. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025288 · Cited by 454
Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
Müller, A., Wenzel, M., Strahl, H., Grein, F., Saaki, T. N. V., Kohl, B., Siersma, T., Bandow, J. E., Sahl, H.-G., Schneider, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611173113 · Cited by 425
Lipopolysaccharide transport and assembly at the outer membrane: the PEZ model
Okuda, S., Sherman, D. J., Silhavy, T. J., Ruiz, N., & Kahne, D. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.25 · Cited by 381
The microbiota protects against respiratory infection via GM-CSF signaling
Brown, R. L., Sequeira, R. P., & Clarke, T. B. (2017) · Nature Communications · doi:10.1038/s41467-017-01803-x · Cited by 378
Self-citationZhou, Z., White, K. A., Polissi, A., Georgopoulos, C., & Raetz, C. R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12466 · Cited by 346
Fivenson, E. M., & Bernhardt, T. G. (2020) · mBio · doi:10.1128/mbio.00939-20 · Cited by 321
Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S.-J., Proctor, R. A., Sahl, H.-G., Schrenzel, J., Xiong, Y. Q., & Bayer, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-07 · Cited by 318
Falagas, M. E., Rafailidis, P. I., Ioannidou, E., Alexiou, V. G., Matthaiou, D. K., Karageorgopoulos, D. E., Kapaskelis, A., Nikita, D., & Michalopoulos, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.005 · Cited by 300
The action mechanism of daptomycin
Taylor, S. D., & Palmer, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.052 · Cited by 298
Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics
MacNair, C. R., Stokes, J. M., Carfrae, L. A., Fiebig-Comyn, A. A., Coombes, B. K., Mulvey, M. R., & Brown, E. D. (2018) · Nature Communications · doi:10.1038/s41467-018-02875-z · Cited by 287
The rise and spread of mcr plasmid-mediated polymyxin resistance
Nang, S. C., Li, J., & Velkov, T. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1492902 · Cited by 255
Linden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
Satlin, M. J., Lewis, J. S., Weinstein, M. P., Patel, J., Humphries, R. M., Kahlmeter, G., Giske, C. G., & Turnidge, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa121 · Cited by 250
Sperandeo, P., Lau, F. K., Carpentieri, A., De Castro, C., Molinaro, A., Dehò, G., Silhavy, T. J., & Polissi, A. (2008) · Journal of Bacteriology · doi:10.1128/jb.00270-08 · Cited by 242
Deris, Z. Z., Akter, J., Sivanesan, S., Roberts, K. D., Thompson, P. E., Nation, R. L., Li, J., & Velkov, T. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.111 · Cited by 216
Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance
Ayoub Moubareck, C. (2020) · Membranes · doi:10.3390/membranes10080181 · Cited by 206
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Tran, T. B., Velkov, T., Nation, R. L., Forrest, A., Tsuji, B. T., Bergen, P. J., & Li, J. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.010 · Cited by 200
Clarke, T. B. (2014) · Infection and Immunity · doi:10.1128/iai.02212-14 · Cited by 189 · cited 1×
“To establish colonisation of the lungs, mice were anesthetised and intranasally inoculated with 107 c. f.u. of P. aeruginosa PA14 in 50 ml of PBS, as described previously (Clarke, 2014; Brown et al., 2017).”
Structural basis of lipopolysaccharide extraction by the LptB2FGC complex
Li, Y., Orlando, B. J., & Liao, M. (2019) · Nature · doi:10.1038/s41586-019-1025-6 · Cited by 166
W. S. Yapa, S., Li, J., Patel, K., Wilson, J. W., Dooley, M. J., George, J., Clark, D., Poole, S., Williams, E., Porter, C. J. H., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01705-13 · Cited by 161
Gram-Negative Outer and Inner Membrane Models: Insertion of Cyclic Cationic Lipopeptides
Clausell, A., Garcia-Subirats, M., Pujol, M., Busquets, M. A., Rabanal, F., & Cajal, Y. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp064757+ · Cited by 159
Mechanism-of-Action Classification of Antibiotics by Global Transcriptome Profiling
O’Rourke, A. E., Beyhan, S., Choi, Y., Morales, P., Chan, A. P.-Y., Espinoza, J. L., Dupont, C. L., Meyer, K. J., Spoering, A. L., Lewis, K., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01207-19 · Cited by 134
Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance
Moore, R. A., & Hancock, R. E. W. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.6.923 · Cited by 133
Antibiotic resistance and adhesion properties of oral Enterococci associated to dental caries
Kouidhi, B., Zmantar, T., Mahdouani, K., Hentati, H. A. A., & Bakhrouf, A. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-155 · Cited by 113
Brennan-Krohn, T., Pironti, A., & Kirby, J. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00873-18 · Cited by 110
Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities
Takayama, K., Qureshi, N., Raetz, C. R., Ribi, E. E., Peterson, J., Cantrell, J. L., Pearson, F. C., Wiggins, J. F., & Johnson, A. G. (1984) · Infection and Immunity · doi:10.1128/iai.45.2.350-355.1984 · Cited by 106
D'Amato, R. F., Thornsberry, C., Baker, C. N., & Kirven, L. A. (1975) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.7.5.596 · Cited by 101
Cell-based screen for discovering lipopolysaccharide biogenesis inhibitors
Zhang, G., Baidin, V., Pahil, K. S., Moison, E., Tomasek, D., Ramadoss, N. S., Chatterjee, A. K., McNamara, C. W., Young, T. S., Schultz, P. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804670115 · Cited by 101
Structure of the essential inner membrane lipopolysaccharide–PbgA complex
Clairfeuille, T., Buchholz, K. R., Li, Q., Verschueren, E., Liu, P., Sangaraju, D., Park, S., Noland, C. L., Storek, K. M., Nickerson, N. N., et al. (2020) · Nature · doi:10.1038/s41586-020-2597-x · Cited by 101
Lehman, K. M., & Grabowicz, M. (2019) · Antibiotics · doi:10.3390/antibiotics8040163 · Cited by 95
Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37
Choi, H., Yang, Z., & Weisshaar, J. C. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006481 · Cited by 91
Novobiocin Enhances Polymyxin Activity by Stimulating Lipopolysaccharide Transport
Mandler, M. D., Baidin, V., Lee, J., Pahil, K. S., Owens, T. W., & Kahne, D. E. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b02283 · Cited by 82
Structure–Activity Relationships of Daptomycin Lipopeptides
Karas, J. A., Carter, G. P., Howden, B. P., Turner, A. M., Paulin, O. K. A., Swarbrick, J., Baker, M. A., Li, J., & Velkov, T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00780 · Cited by 80
Polymyxin B Loosens Lipopolysaccharide Bilayer but Stiffens Phospholipid Bilayer
Fu, L., Wan, M., Zhang, S., Gao, L., & Fang, W. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.11.008 · Cited by 70
Pulmonary Exacerbations in Adults With Cystic Fibrosis
Stanford, G. E., Dave, K., & Simmonds, N. J. (2021) · Chest · doi:10.1016/j.chest.2020.09.084 · Cited by 70
Li, Z., & Velkov, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16373-0_4 · Cited by 68
Betts, J. W., Sharili, A. S., Ragione, R. M. L., & Wareham, D. W. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00286 · Cited by 67
Khadka, N. K., Aryal, C. M., & Pan, J. (2018) · ACS Omega · doi:10.1021/acsomega.8b02260 · Cited by 66
Furniss, R. C. D., Dortet, L., Bolland, W., Drews, O., Sparbier, K., Bonnin, R. A., Filloux, A., Kostrzewa, M., Mavridou, D. A. I., & Larrouy-Maumus, G. J. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01427-19 · Cited by 54
Self-citationSynergistic effects of Miconazole and Polymyxin B on microbial pathogens
Pietschmann, S., Hoffmann, K., Voget, M., & Pison, U. (2008) · Veterinary Research Communications · doi:10.1007/s11259-008-9194-z · Cited by 46
Lactococcal membrane-permeabilizing antimicrobial peptides
Zendo, T., Yoneyama, F., & Sonomoto, K. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2764-3 · Cited by 44
The use of polymyxins to treat carbapenem resistant infections in neonates and children
Thomas, R., Velaphi, S., Ellis, S., Walker, A. S., Standing, J. F., Heath, P. T., Sharland, M., & Donà, D. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1559817 · Cited by 43
Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence
Garg, S. K., Singh, O., Juneja, D., Tyagi, N., Khurana, A. S., Qamra, A., Motlekar, S. A., & Barkate, H. V. (2017) · Critical Care Research and Practice · doi:10.1155/2017/3635609 · Cited by 36
Lam, J. S., Anderson, E. M., & Hao, Y. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0473-0_31 · Cited by 34
Simple and rapid detection of bacteria using a nuclease-responsive DNA probe
Lee, K. J., Lee, W. S., Hwang, A., Moon, J., Kang, T., Park, K., & Jeong, J. (2017) · The Analyst · doi:10.1039/c7an01384a · Cited by 33
Polymyxins and Analogues Bind to Ribosomal RNA and Interfere with Eukaryotic Translation in Vitro
McCoy, L. S., Roberts, K. D., Nation, R. L., et al. (2013) · ChemBioChem · doi:10.1002/cbic.201300496 · Cited by 31
Janssen, A., Bartholomew, T., Marciszewska, N. P., Bonten, M., Willems, R., Bengoechea, J., & van Schaik, W. (2019) · Msphere · doi:10.1128/msphere.00143-20 · Cited by 31
Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models
Melchers, M. J. B., Teague, J., Warn, P. A., Hansen, J. U., Bernardini, F., Wach, A., Obrecht, D., Dale, G. E., & Mouton, J. W. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01699-18 · Cited by 28
Modes of Action of Antibacterial Agents
Allison, D., & Lambert, P. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00032-9 · Cited by 23
Hoppe, K. A., Hađina, S., Kilburg-Basnyat, B. J., Wang, Y., Chavez, D., Thorne, P. S., & Weiss, J. P. (2017) · Innate Immunity · doi:10.1177/1753425917694084 · Cited by 19
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Verdial, C., Serrano, I., Tavares, L., Gil, S., & Oliveira, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041221 · Cited by 71
Mafe, A. N., & Büsselberg, D. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070820 · Cited by 18
Brown, A. N., Anderson, M. T., Smith, S. N., Bachman, M. A., & Mobley, H. L. T. (2023) · mBio · doi:10.1128/mbio.01448-23 · Cited by 14
Metadata
- Authors
- Sabnis, A., Hagart, K. L., Klöckner, A., Becce, M., Evans, L. E., Furniss, R. C. D., Mavridou, D. A., Murphy, R., Stevens, M. M., Davies, J. C., Larrouy-Maumus, G. J., Clarke, T. B., & Edwards, A. M.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2021-04-06
- Volume
- 10
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W3140198700
- Cited by
- 389
- References
- 68
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.